CNS Pharmaceuticals Inc.
CNSP
CNS Pharmaceuticals, Inc. ( CNS, the Company, we, us, or our ) is a biotechnology company focused on developing innovative therapies for serious diseases in neurology and oncology. Together, these therapeutic areas represent hundreds of billions of dollars in annual global pharmaceutical spending, encompass some of the most prevalent and difficult to treat diseases affecting humanity, …
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$16M
▼ -6.7% YoY
Op. Margin
–
ROIC
-131.08%
▲ +123.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$14M
▲ +19.2% YoY
Op. Cash Flow (TTM)
-$14M
▲ +19.3% YoY
Net Debt
-$17M
Net Cash Position
Cash & Equiv.
$17M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with CNSP
CNS Pharmaceuticals (CNSP) in two numbers
Questions about CNS Pharmaceuticals
Does CNS Pharmaceuticals (CNSP) pay a dividend?
No. CNS Pharmaceuticals (CNSP) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 15 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in CNSP's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CNSP
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.